Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.85 USD
-0.05 (-1.72%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $2.85 0.00 (0.00%) 7:40 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Generation Bio Co falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 264 | 279 | 375 | 262 | 15 |
Receivables | 4 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 8 | 4 | 5 | 3 |
Total Current Assets | 273 | 287 | 379 | 268 | 18 |
Net Property & Equipment | 26 | 22 | 26 | 24 | 22 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 6 | 7 | 6 | 2 | 2 |
Total Assets | 375 | 376 | 477 | 294 | 42 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 2 | 0 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 17 | 11 | 12 | 11 | 7 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 13 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 40 | 19 | 19 | 11 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 42 | 0 | 0 | 15 | 16 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 172 | 94 | 95 | 26 | 25 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 116 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 774 | 727 | 690 | 457 | 10 |
Retained Earnings | -571 | -445 | -308 | -189 | -108 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 203 | 282 | 382 | 268 | 17 |
Total Liabilities & Shareholder's Equity | 375 | 376 | 477 | 294 | 42 |
Total Common Equity | 203 | 282 | 382 | 268 | -99 |
Shares Outstanding | 66.00 | 59.40 | 56.90 | 55.70 | NA |
Book Value Per Share | 3.08 | 4.76 | 6.71 | 4.81 | 0.00 |
Fiscal Year End for Generation Bio Co falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 264 | 291 | 314 | 289 |
Receivables | NA | 4 | 1 | 0 | 49 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 4 | 6 | 6 | 7 |
Total Current Assets | NA | 273 | 298 | 321 | 345 |
Net Property & Equipment | NA | 26 | 22 | 22 | 22 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 6 | 6 | 6 | 6 |
Total Assets | NA | 375 | 381 | 405 | 431 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 17 | 9 | 8 | 8 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 13 | 12 | 8 | 6 |
Total Current Liabilities | NA | 40 | 33 | 26 | 23 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 42 | 46 | 52 | 55 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 172 | 150 | 151 | 152 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 774 | 768 | 762 | 756 |
Retained Earnings | NA | -571 | -536 | -508 | -477 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 203 | 232 | 254 | 279 |
Total Liabilities & Shareholder's Equity | NA | 375 | 381 | 405 | 431 |
Total Common Equity | 0 | 203 | 232 | 254 | 279 |
Shares Outstanding | 66.40 | 66.00 | 65.90 | 65.90 | 65.60 |
Book Value Per Share | 0.00 | 3.08 | 3.52 | 3.86 | 4.26 |